NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 152 filers reported holding NEVRO CORP in Q2 2024. The put-call ratio across all filers is 35.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $14,303,627 | -44.2% | 1,698,768 | -4.4% | 0.45% | -45.7% |
Q1 2024 | $25,650,754 | -32.9% | 1,776,368 | 0.0% | 0.83% | -41.1% |
Q4 2023 | $38,227,439 | +12.0% | 1,776,368 | 0.0% | 1.40% | +30.1% |
Q3 2023 | $34,141,793 | -24.4% | 1,776,368 | 0.0% | 1.08% | -26.8% |
Q2 2023 | $45,155,275 | -23.5% | 1,776,368 | +8.8% | 1.48% | -24.2% |
Q1 2023 | $59,029,877 | +25.0% | 1,632,915 | +37.0% | 1.95% | +23.1% |
Q4 2022 | $47,215,001 | – | 1,192,298 | – | 1.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Engaged Capital LLC | 1,885,956 | $15,879,750 | 2.72% |
Kent Lake Capital LLC | 639,775 | $5,386,906 | 2.43% |
Wellington Wealth Strategies, LLC. | 71 | $538,662 | 2.26% |
Palo Alto Investors LP | 750,371 | $6,318,124 | 0.73% |
BRAIDWELL LP | 1,698,768 | $14,303,627 | 0.45% |
ArrowMark Colorado Holdings LLC | 4,289,108 | $36,114,289 | 0.43% |
ARMISTICE CAPITAL, LLC | 3,672,000 | $30,918,240 | 0.39% |
Rock Springs Capital Management LP | 1,381,500 | $11,632,230 | 0.35% |
Eversept Partners, LP | 499,395 | $4,204,906 | 0.29% |
Olympiad Research LP | 25,046 | $210,887 | 0.16% |